IP Library Granted Patent US 9,926,309
Granted Patent B2
US 9,926,309 · App. 15/055,403 · Granted Mar 27, 2018

Pi-kinase inhibitors with anti-infective activity

Inventors: Jeffrey S. Glenn (Palo Alto, CA); Michael A. Gelman (Stanford, CA); Brandon Tavshanjian (San Francisco, CA); Kevan Shokat (San Francisco, CA); Ingrid Choong (Los Altos, CA); Mark Smith (San Francisco, CA)
Assignees: The Board of Trustees of the Leland Stanford Junior University; The Regents of the University of California
C07D417/14C07D277/42C07D277/44C07D277/46C07D417/04C07D417/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,926,309
App. No.
15/055,403
Granted
Mar 27, 2018
Kind
B2
Abstract

Compounds and methods are provided for the treatment of pathogen infections. In some embodiments, the anti-infective compounds have broad spectrum activity against a variety of infective diseases, where the diseases are caused by pathogens containing a basic amino acid PIP-2 pincer (BAAPP) domain that interacts with phosphatidylinositol 4,5-bisphosphate (PIP-2) to mediate pathogen replication. Also provided are methods of inhibiting a PI4-kinase and methods of inhibiting viral infection. In some embodiments, the compound is a PI4-kinase inhibiting compound that is a 5-aryl-thiazole or a 5-hetereoaryl-thiazole. The subject compounds may be formulated or provided to a subject in combination with a second anti-infective agent, e.g. interferon, ribivarin, and the like.

Claims (75)

1. A compound of the formula (XXI)

wherein:

R 2 is an alkoxy or a substituted alkoxy;

R 3 is hydrogen, a lower alkyl or a substituted lower alkyl;

Y 3 is N;

Z 2 is absent, CO or SO 2 ;

R 1 is an aryl, a substituted aryl, an alkyl, a substituted alkyl, a cycloalkyl, a substituted cycloalkyl, a heterocycle, a heteroaryl, a substituted heteroaryl or a substituted heterocycle; and

R 4 is selected from alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkyl-cycloalkyl, substituted alkyl-cycloalkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, alkyl-heterocycle and substituted alkyl-heterocycle;

or a prodrug thereof, or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein the compound is of formula (XXII):

wherein:

R 10 is selected from cycloalkyl, substituted cycloalkyl, heterocycle and substituted heterocycle; and

R 51 and R 52 are independently selected from H, halogen, alkyl and substituted alkyl.

3. The compound of claim 2 , wherein the compound is of formula (XXIII):

wherein:

R 31 -R 35 are independently selected from hydrogen, halogen, alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, acyl, substituted acyl and —CO 2 R, wherein R is H, alkyl or substituted alkyl.

4. The compound of claim 2 , wherein the compound is of formula (XXXI):

wherein:

each (R) n is one or more optional substituents each independently selected from alkyl, substituted alkyl, hydroxyl, alkoxy, substituted alkoxy, halogen and CO 2 R″ wherein R″ is hydrogen, alkyl or substituted alkyl.

5. The compound of claim 3 , wherein the compound is of formula (XXXII):

R 31 -R 33 and R 35 are independently selected from hydrogen and halogen;

(R) n is one or more optional substituents each independently selected from alkyl, substituted alkyl, hydroxyl, alkoxy, substituted alkoxy, halogen and CO 2 R″ wherein R″ is hydrogen, alkyl or substituted alkyl; and

R′ is H, alkyl or substituted alkyl.

6. The compound of claim 1 , wherein the compound is of formula (XXXIV):

wherein:

R 2 is an alkoxy or a substituted alkoxy;

R 3 is hydrogen, a lower alkyl or a substituted lower alkyl;

R 1 is an aryl, a substituted aryl, a heteroaryl, a substituted heteroaryl a cycloalkyl, a substituted cycloalkyl, a heterocycle or a substituted heterocycle; and

R 4 is selected from cycloalkyl, substituted cycloalkyl, alkyl-cycloalkyl, substituted alkyl-cycloalkyl, heterocycle, substituted heterocycle, alkyl-heterocycle and substituted alkyl-heterocycle.

7. The compound of claim 1 , wherein the compound is of formula (XXXIX):

wherein:

R 41 is hydrogen, a lower alkyl or a substituted lower alkyl; and

R 42 is selected from cycloalkyl, substituted cycloalkyl, alkyl-cycloalkyl, substituted alkyl-cycloalkyl, heterocycle, substituted heterocycle, alkyl-heterocycle and substituted alkyl-heterocycle.

8. The compound of claim 7 , wherein the compound is of formula (XLV):

wherein:

R 31 -R 35 are independently selected from hydrogen, halogen, alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, acyl, substituted acyl and —CO 2 R, wherein R is H, alkyl or substituted alkyl.

9. The compound of claim 8 , wherein the compound is of formula (XLVII):

wherein:

(R) n is one or more optional substituents each independently selected from alkyl, substituted alkyl, hydroxyl, alkoxy, substituted alkoxy, halogen and CO 2 R″ wherein R″ is hydrogen, alkyl or substituted alkyl.

10. The compound of claim 1 , wherein the compound is of formula (XLVIII):

wherein R 1 is selected from heteroaryl, substituted heteroaryl, aryl and substituted aryl.

11. The compound of claim 10 , wherein R 4 is methyl, isopropyl, cyclohexyl, substituted cyclohexyl, phenyl, substituted phenyl, benzyl, substituted benzyl or —CH 2 -4-tetrahydropyran.

12. A new compound of one of the formulae:

wherein:

R 1 is selected from heteroaryl, substituted heteroaryl, aryl and substituted aryl;

R 2 is an alkoxy or a substituted alkoxy;

R 3 is hyrdrogen, a lower alkyl or a substituted lower aryl;

R 4 is a lower alkyl or a substituted lower alkyl;

R 11 is an aryl, a substituted aryl, a heteroaryl, a substituted heteroaryl, a cycloalkyl, a substituted cycloalkyl, a hetercycle or a substituted heterocycle;

R 14 is selected from alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkyl-cycloalkyl, substituted alkyl-cycloalkyl, aryl, substituted aryl, heterocycle, substituted heterocycle, alkyl-heterocycle and substituted alkyl-heterocycle;

R 31 -R 35 are independently selected from hydrogen, halogen, alkyl, substituted alkyl, hydroxyl, alkkoxy, substituted alkoxy, acyl, substituted acyl and —CO 2 R′, wherein R′ is H, alkyl or substituted alkyl;

R 41 is hydrogen, a lower alkyl or a substituted lower alkyl; and

R 42 is selected from cycloalkyl, substituted cycloalkyl, alkyl-cycloalkyl, substituted alkyl-cycloalkyl, heterocycle, substituted heterocycle, alkyl-heterocycle and substituted alkyl-heterocycle;

(R) n is one or more optional substitutents each independently selected from alkyl, substituted alkyl, hydroxyl, alkoxy, substituted alkoxy, halogen, and CO 2 R″ wherein R″ is hydrogen, alkyl or substituted alkyl; and

Y 11 and Y 12 are selected from CR″ 2 , NR″ and O, wherein each R″ is independently H, R, an acyl or a substituted acyl.

13. The compound of claim 12 , wherein the compound is formula (XIX) or (XXX).

14. The compound of claim 12 , wherein the compound is of formula (XLIX), wherein R 14 is methyl, isopropyl, cyclohexyl, substituted cyclohexyl, phenyl, substituted phenyl, benzyl, substituted benzyl or —CH 2 -4-tetrahydropyran.

15. The compound of claim 12 , wherein the compound is of formula (XXXV) or (XXXVI).

16. The compound of claim 12 , wherein the compound is of formula (XL) or (XLI).

17. The compound of claim 16 , wherein R 42 is a heterocycle or substituted heterocycle.

18. The compound of claim 12 , wherein the compound is of formula (XLIV).

19. The compound of claim 18 , wherein the compound is of formula (XLVI):

wherein:

(R) n is one or more optional substituents each independently selected from alkyl, substituted alkyl, hydroxyl, alkoxy, substituted alkoxy, halogen and CO 2 R″ wherein R″ is hydrogen, alkyl or substituted alkyl.

20. A compound of formula (III):

wherein:

R 2 is alkoxy or substituted alkoxy;

R 3 is alkoxy or a substituted alkly;

W 1 is —SO 2 —;

W 2 is —NH—;

R 4 is alkyl-heterocyclyl or a substituted alkyl-heterocyclyl;

R 1 is selected from:

wherein:

Z 13 is CR 23 or N, Z 3 is N or CR 11 and Z 4 is N or CR 13 ; and

R 11 to R 15 and R 22 -R 26 are each independently selected from hydrogen, an alkyl, an aryl, hydroxyl, an alkoxy, a heterocycle, cyano, a halogen, an amino, an acyl, an acyloxy, an amido and nitro.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jul 11, 2016
From: STANFORD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039298/0697 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 038819 FRAME: 0489. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 10, 2016
From: TAVSHANJIAN, BRANDON; SHOKAT, KEVAN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038950/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2016
From: GLENN, JEFFREY S.; GELMAN, MICHAEL A.; CHOONG, INGRID; SMITH, MARK
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 038819/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2016
From: SHOKAT, KEVAN; TAVSHANJIAN, BRANDON
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038819/0489 →
Continuity (3)
Continuation In Part 14348864
Provisional Application 61543538 · Oct 5, 2011
Related Publication 20160194314A1 · Jul 7, 2016